Src Inhibition with Saracatinib Reverses Fulvestrant sorted by
relevance

Admin15.07.2021

Src Inhibition with Saracatinib Reverses Fulvestrant

5601
Admin08.09.2021

Src Inhibition with Saracatinib Reverses Fulvestrant

Admin03.08.2021

Figure 4 from Cancer Therapy : Preclinical Src Inhibition

3401
Admin22.08.2021

(PDF) Src Inhibition with Saracatinib Reverses Fulvestrant

46010
Admin05.08.2021

Src Inhibition with Saracatinib Reverses Fulvestrant

607
Admin02.08.2021

(PDF) Src Inhibition with Saracatinib Reverses Fulvestrant

84010
Admin07.08.2021

Figure 1 from Cancer Therapy : Preclinical Src Inhibition

5205
Admin30.08.2021

Saracatinib increases ER protein levels and transcription

800
Admin23.08.2021

Fulvestrant and saracatinib effects on MDA-MB-361 breast

8302
Admin22.07.2021

Estrogen activates Src, ER/Src binding, and ER

3106
Admin29.07.2021

Fulvestrant and saracatinib effects on MDA-MB-361 breast

1203
Admin26.08.2021

src inhibition attenuates gemcitabine resistance

5804
Admin18.08.2021

Src Inhibition with Saracatinib Reverses Fulvestrant

8001
Admin08.09.2021

src inhibition attenuates gemcitabine resistance

2202
Admin01.08.2021

Ls180 Cells | ATCC | Bioz

1501
Admin06.08.2021

Src inhibition by Src siRNA induces melanogenesis and

200
Admin23.08.2021

Src Inhibition Can Synergize with Gemcitabine and Reverse

6305
Admin18.09.2021

Fulvestrant and saracatinib effects on MDA-MB-361 breast

7402
Admin18.07.2021

Fulvestrant and saracatinib effects on MDA-MB-361 breast

Admin30.09.2021

Inhibition of Src kinase reverses ERα overexpression

3908
Admin04.10.2021

(PDF) Inhibition of pp60c-Src reduces BCL-XL expression

403